Provided by Tiger Trade Technology Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.9721
+0.08109.09%
Post-market: 0.97210.00000.00%16:20 EDT
Volume:1.14M
Turnover:1.12M
Market Cap:123.53M
PE:-2.18
High:1.00
Open:0.9179
Low:0.9100
Close:0.8911
52wk High:4.31
52wk Low:0.6810
Shares:127.08M
Float Shares:67.47M
Volume Ratio:0.65
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4464
EPS(LYR):-0.4673
ROE:-36.21%
ROA:-20.83%
PB:0.94
PE(LYR):-2.08

Loading ...

Nautilus Biotechnology May Offer up to $300 Million of Securities - SEC Filing

Reuters
·
Sep 12

Nautilus Biotechnology files $300M mixed securities shelf

TIPRANKS
·
Sep 12

Nautilus Biotechnology Signs TD Cowen for up to USD 125 Million ATM Equity Offering

Reuters
·
Sep 12

Nautilus Biotechnology - May Offer up to $125 Mln Common Stock Under Sales Agreement with TD Securities - SEC Filing

THOMSON REUTERS
·
Sep 12

Leerink Partners Initiates Coverage on Nautilus Biotechnolgy With Outperform Rating, $4 Price Target

MT Newswires Live
·
Sep 09

Nautilus Biotechnology initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms

GlobeNewswire
·
Sep 04

Undervalued Penny Stocks To Consider In August 2026

Simply Wall St.
·
Aug 25

Nautilus Biotechnology Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 28

Nautilus Biotechnology Posts First Revenue, Q2 Net Loss Narrows

Reuters
·
Jul 28

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 28

Nautilus Biotechnology Q2 Operating Expenses USD 15.938 Million

THOMSON REUTERS
·
Jul 28

Nautilus Biotechnology Q2 EPS USD -0.11

THOMSON REUTERS
·
Jul 28

Nautilus Biotechnology Q2 EPS $(0.11) Beats $(0.14) Estimate, Sales $190.000K

Benzinga Earnings
·
Jul 28

Nautilus Biotechnology Inc Expected to Post a Loss of 13 Cents a Share - Earnings Preview

Reuters
·
Jul 24

Nautilus Biotechnology And 2 Promising Penny Stocks To Consider

Simply Wall St.
·
Jul 11

Nautilus Biotechnology to Report Q2 Results, Host Conference Call

Reuters
·
Jul 08

Nautilus Biotechnology shareholders elect Class II directors Mallick, Nazem at annual meeting

Reuters
·
Jun 19

AH Equity Partners Bio II disposes of 5,000,000 Nautilus Biotechnology shares worth $11,750,000

Reuters
·
Jun 05

Guggenheim Remains a Buy on Nautilus Biotechnolgy (NAUT)

TIPRANKS
·
Apr 29